Cyted, which works on non-endoscopic diagnostics for digestive diseases, has appointed Gail Marcus as its chair and a non-executive director.

Cancer Research Horizons has appointed Jonathan Tobin and Genghis Lloyd-Harris as advisory investors-in-residence in its ventures team.

The transaction comes on the heels of the immuno-oncology contract research business, Antibody Analytics, which was acquired in early November.

NanoSyrinx has appointed Dr Anthony Johnson as a non-executive director.

Kelso Pharma, a UK-based specialty pharma business, has acquired an Italian specialty pharma company as part of its European expansion plans.

Enhanc3D Genomics has appointed Hazel Jones as chief operating officer.

Recruitment company The IN Group has acquired BioTalent, a life sciences recruitment specialist.

NorthEdge has completed a multimillion-pound investment into Antibody Analytics, a contract research organisation.

M&G Investments has invested in SkyCell, which supplies containers and technological solutions for delivery of pharmaceuticals.

Kelso Pharma has acquired two UK approved products from an organisation within the Dermapharm Group.

Biotech company Mestag Therapeutics has appointed Dr Cassandra Choe-Juliak, Dr Greg Elson and Samantha Vieira as expert advisors.

AstronauTx has completed a £48 million Series A financing led by the Novartis Venture Fund.

Closed Loop Medicine has appointed Konstantinos Vlassis as chief technology officer.

Forward Partners-backed Sonrai Analytics, an AI precision medicine company, has appointed Paul Jones as chairman.

Cambridge-based techbio company Qureight has appointed Dr Claus Torp Jensen as its chairperson.

Biotechnology company CellCentric, has secured a further $3 million investment from BrightEdge.

Private equity firm Permira has agreed to buy Guildford-based biopharmaceutical company Ergomed for about £703.1 million.

Optibrium has acquire BioPharmics, a developer of algorithms and software for 3D ligand and structure-based computational drug design.

Glasgow-based digital pharmacy company Phlo Technologies has appointed Alistair Murray as chief pharmacist. 

Destiny Pharma has appointed Sir Nigel Rudd as chairman.

Destiny Pharma has appointed Chris Tovey as chief executive.

A global clinical trials company is making preparations for its highly-anticipated second round of bidding.

London-based Tenpoint Therapeutics has raised $70 million Series A financing to continue developing eye therapeutics.

Camena Bioscience has closed a $10 million Series A financing round, led by Mercia.

EDX Medical Group has appointed Dr Keti Zeka as head of R&D and director of laboratories and Dr Liam Dower as head of quality, regulatory affairs and compliance.

Avacta Group, a life sciences company developing oncology drugs and diagnostics, has appointed Shaun Chilton as a non-executive director.

TMC Pharma Services has appointed Stewart Sharpe as chief commercial officer.

Pneumagen, a clinical stage biotech company, has secured £8 million in financing.

Chancellor of the Exchequer Jeremy Hunt has revealed a £650 million war chest to bolster economic growth in the UK's Life Sciences sector.

EQT Life Sciences has closed its inaugural LSP Dementia Fund, raising approximately €260 million.

Neuro-Bio, an Abingdon-based biotech company with a therapeutic focus on Alzheimer’s Disease, will close a £10m Series C round by Q3 2023.

Kester Capital, a UK lower mid-market private equity specialist, has invested in MAP Patient Access, a consulting services provider to the pharmaceutical and biotech sectors, Private Equity Wire has reported.

Mansfield Advisors has appointed Dr Misha Engineer and Dr Ed Kanalosh as senior advisors.